Effect of hypothalamic lesions on pituitary-adrenocortical responses to histamine and methopyrapone.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000311:Adrenal Glands / Q000098:blood supply; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000818:Animals; D004285:Dogs; D006632:Histamine / Q000494:pharmacology*; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D007031:Hypothalamus / Q000502:physiology*; D008797:Metyrapone / Q000494:pharmacology*; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D012636:Secretory Rate; D013238:Stereotaxic Techniques; D013312:Stress, Physiological; D013788:Thalamus / Q000502:physiology
D015065:17-Hydroxycorticosteroids; D006632:Histamine; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone